ATE199253T1 - Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen - Google Patents

Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen

Info

Publication number
ATE199253T1
ATE199253T1 AT93401083T AT93401083T ATE199253T1 AT E199253 T1 ATE199253 T1 AT E199253T1 AT 93401083 T AT93401083 T AT 93401083T AT 93401083 T AT93401083 T AT 93401083T AT E199253 T1 ATE199253 T1 AT E199253T1
Authority
AT
Austria
Prior art keywords
triazolones
halophenylpiperazinyl
antidepressant
substituted
trifluoromethyl
Prior art date
Application number
AT93401083T
Other languages
English (en)
Inventor
Robert F Mayol
George M Luke
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE199253T1 publication Critical patent/ATE199253T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93401083T 1992-04-28 1993-04-26 Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen ATE199253T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/875,044 US5256664A (en) 1992-04-28 1992-04-28 Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones

Publications (1)

Publication Number Publication Date
ATE199253T1 true ATE199253T1 (de) 2001-03-15

Family

ID=25365103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93401083T ATE199253T1 (de) 1992-04-28 1993-04-26 Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen

Country Status (10)

Country Link
US (1) US5256664A (de)
EP (1) EP0568437B1 (de)
JP (1) JPH0641095A (de)
AT (1) ATE199253T1 (de)
CA (1) CA2094890C (de)
DE (1) DE69329942T2 (de)
DK (1) DK0568437T3 (de)
ES (1) ES2154644T3 (de)
GR (1) GR3035809T3 (de)
PT (1) PT568437E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6465469B1 (en) 1999-04-09 2002-10-15 Sepracor Inc. S-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
WO2000061128A2 (en) * 1999-04-09 2000-10-19 Sepracor Inc. R-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
JP3850224B2 (ja) 2001-03-26 2006-11-29 株式会社ジェイテクト 研削加工方法及び数値制御研削盤
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2356450C (en) * 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders

Also Published As

Publication number Publication date
US5256664A (en) 1993-10-26
EP0568437B1 (de) 2001-02-21
CA2094890C (en) 2000-04-11
GR3035809T3 (en) 2001-07-31
JPH0641095A (ja) 1994-02-15
DE69329942T2 (de) 2001-08-16
ES2154644T3 (es) 2001-04-16
EP0568437A1 (de) 1993-11-03
DK0568437T3 (da) 2001-04-30
PT568437E (pt) 2001-06-29
CA2094890A1 (en) 1993-10-29
DE69329942D1 (de) 2001-03-29

Similar Documents

Publication Publication Date Title
ATE199253T1 (de) Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen
DE69418704D1 (de) Anthranilsäure derivate
DE69817393D1 (de) Neue heterozyklische verbindungen
CA2194503A1 (en) 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use
DE69725978D1 (de) Chalcon-derivate und medikamente die diese enthalten
IL100756A0 (en) Imidazole,triazole and tetrazole derivatives,their preparation and pharmaceutical compositions containing them
ATE210635T1 (de) Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
DE69701298D1 (de) Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
PT992509E (pt) Novos derivados macrolidos
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
EE200000059A (et) Tetrahüdro-gamma-karboliinid
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
NO302821B1 (no) Aminobenzosyrederivat, preparat omfattende derivatet og anvendelse av derivatet
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
DE69523819D1 (de) Quinolin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
EP0919233B8 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
ATE207918T1 (de) Substituierte 6-r-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetische, cardiovaskulare und hypometabolische mittel, und eine sie enthaltende pharmazeutische zubereitung
SE9901237D0 (sv) Novel use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee